Vito Mangiardi has been appointed chief executive officer, Bilcare Global Clinical Supplies. Mohan Bhandari, chairman and managing director, Bilcare Ltd., said, “Vito is an exceptional leader and strategist. He has vast experience in global business management, pharmaceutical and biotech contract research and development services, and extensive expertise in clinical supplies. Vito’s breadth and depth of experience is unsurpassed in the industry and he is a perfect fit for Bilcare GCS as we continue to experience steady growth.”
   
Mr. Mangiardi has 30 years of experience in the clinical supplies, pharmaceutical and biotech industries. He has held key leadership positions throughout his career, most recently serving as president of North American Operations for AAI Pharma where he was responsible for Phase I, formulation development, analytical development, bio-analytical, manufacturing and stability testing, as well as Phase II-IV clinical trials.  
   
Prior to joining AAI Pharma, Mr. Mangiardi served as senior vice president and chief operating officer of global Phase IV services at Quintiles Transnational. He also held other executive level positions at Quintiles including head of the International Clinical Development Services group in Japan, head of the Asia Pacific Business and executive vice president of Operational Services of Quintiles Americas.  
   
Bilcare GCS has also added to its global management team. Reporting to Mr. Mangiardi are: David Laskow Pooley, leading the company’s European operations, Vincent Santa Maria, leading the American operations, and Ajit Dubhashi, leading the Asian operations.